On May 20, 2026, Bozeman, Montana-based sexual-health wearable company FirmTech announced its inaugural "Orgasm-A-Day Challenge" — a June-long contest that will award $500 to the FirmTech TechRing user who tracks the most sex- or solo-induced erections during the month. The leaderboard closes at midnight on June 30, and the company is explicitly framing the contest as a Men's Health Month publicity push tied to its underlying clinical thesis that erectile activity is a non-invasive proxy for cardiovascular and overall health.

Why It Matters

The Orgasm-A-Day Challenge is a marketing stunt, but the underlying product thesis is the more durable story. The men's-sexual-health diagnostic category remains structurally underbuilt relative to its female counterpart (which has at least Joylux, Lioness, Perifit, and Elvie consumer products with sensor-driven feedback loops). FirmTech is the most-visible US-based entrant attempting to build an Apple Watch-grade quantified-self loop for erectile function — and the public-data play around 240,000+ tracked erections is exactly the kind of dataset that, at scale, becomes investable IP. For telehealth ED platforms (Hims, Ro, BlueChew, Lemonaid), the existence of a consumer wearable that produces independent erectile-fitness data changes the diagnostic conversation from patient-reported to sensor-confirmed — with implications for both prescription protocols and outcomes measurement.

The TechRing is a $275 sensor-equipped cock ring with Bluetooth, 12-hour battery, USB-C charging, and a medical-grade elastomer adjustable to most users up to 5.5" erect girth. The companion FirmTech app aggregates erection frequency, firmness, and duration into an Erectile Fitness Score that the company pitches as a quantified self-tracking metric in the same category as VO2 max, HRV, and resting heart rate. To date, FirmTech says it has documented 240,000+ erections across 4,000+ users — a meaningful real-world dataset for a category that has historically operated on patient-reported survey instruments like the IIEF-5.

The Orgasm-A-Day publicity gambit lands at an inflection point for the men's-sexual-health wearable category. With Hims & Hers' Q1 2026 revenue miss and the Novo Nordisk Wegovy pivot, the at-home ED-treatment market is consolidating around branded telehealth platforms — but the diagnostic side of the funnel (knowing whether you actually have a problem before reaching for sildenafil) remains underbuilt. FirmTech, co-founded by urologist Dr. Elliot Justin and University of Utah men's-health surgeon Dr. James Hotaling, has been the most-cited pre-clinical-grade entrant in that diagnostic gap.

Dr. Justin's framing in the press release pushes the message hardest: "Sexual health is not separate from overall health. It is tied to mood, stress, confidence, relationships, and long-term wellness." The contest mechanics — a sex-tracking competition with a cash prize tied to nocturnal and partnered erections alike — are the kind of attention-grabbing marketing that's been historically hard to land in mainstream press for sex-tech wearables, and the company appears to be threading the needle by leaning into the Men's Health Month brand alignment.

Sources

Update — 2026-05-21

Initial entry — story first created.